Quince Therapeutics, Inc. , a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient’s own biology to deliver rare disease therapeutics,.
Cash Position Expected to Accelerate Revenue Growth, Fuel SOBRsafe Beyond 2023DENVER, CO / ACCESSWIRE / October 26, 2022 / SOBR Safe, Inc. (NASDAQ:SOBR) (SOBRsafe or the Company), providers of industry-leading